Robert J. Fox, MD.
Dr. Robert J. Fox serves as the Managing Director of the NARCOMS MS Patient Registry, which currently follows over 12,000 MS patients. He is Staff Neurologist at the Mellen Center for Multiple Sclerosis and Vice-Chair for Research of the Neurological Institute, Cleveland Clinic. Dr. Fox’s current research interests focus clinical trials in multiple sclerosis, innovative MRI techniques to evaluate tissue recovery after injury and the effects of MS treatments, as well as MS patient decision-making and tolerance to risk. He serves as an advisor for many clinical trials, including the principal investigator of the NIH-funded Phase II SPRINT-MS trial of ibudilast in progressive MS.